Chris Carswell

Editor in Chief PharmacoEconomics. Past President ISPOR NZ Chapter, ex pharmacist, run and play the piano. UK expat in New Zealand. All views are my own

[Chris Carswell @PECjournal]

https://t.co/wtNxou48s5

[Chris Carswell @PECjournal]

PharmacoEconomics has a Call For Papers for a themed issue on individual level models https://t.co/wlU877kHZW

[Patient Journal @PatientJournal]

A much needed reporting checklist for discrete choice experiments https://t.co/mh7B2k0tfq

[Chris Carswell @PECjournal]

Seems to me the QALY is so entrenched in many countries it would take a huge effort to move away from it

[Stephanie Harvard @newsvava]

Second, this solo editorial in Pharmacoeconomics, called "Making Models Fit for Purpose: the Importance of Ensuring Stakeholder Involvement". Also available free right here! https://t.co/wfQUXQ15Jq

[Mike Paulden @mikepaulden]

My 'Framework for the Fair Pricing of Medicines' has just been published as a Leading Article by Pharmacoeconomics. This framework proposes a number of advancements to existing approaches for specifying a 'cost-effectiveness threshold' for new medicines. https://t.co/QCOD9Ya2D1

[Hareth Al-Janabi @HajBrum]

Including carer outcomes in economic evaluation is important & can reveal unrecognised challenges in HTA decisions.

One of these is where patient & carer QALYs point in different directions - work led by @davidjohnmott and colleagues @OHENews @HEU_UoB

https://t.co/c9tWwBmx3r

[nance devlin @nancydevlin1]

1/3 "Using Age-Specific Values for Pediatric HRQoL in CEA: Is There a Problem to Be Solved? If So, How?" available here👉 https://t.co/k4pT7cZiMp
Really pleased this paper is out - hope it serves to progress the debate! @stolk_elly @MJSculpher @rich_norman @QUOKKA_Research

[Chris Carswell @PECjournal]

@PaulaLorgelly Thanks for the tip!

[Chris Carswell @PECjournal]

@DonHusereau will be pleased

[Adam Raymakers @AdamR_PhD]

@Eddie_Cliff @darioT_ @amarkelkar @oncology_bg @ManniMD1 @TheLancetOncol This article is also a helpful explanation of CEA models (and more specifically how they can be manipulated). Definitely a favourite and worth a read IMO!

CC: @PECjournal
https://t.co/SzaIklmYwZ

[dr cate bailey @catebailey1]

Thread update on the QUOKKA project led by the brilliant @nancydevlin1 - huge output from this multi-university project on measuring and valuing child QoL

[Chris Carswell @PECjournal]

@CJHSaunders @DHPalliative @DartmouthInst @DartmouthHealth @glynelwyn you have included the twitter handle for PharmacoEconomics - not Patient Education and Counselling :(

[Chris Carswell @PECjournal]

Terrible grammar is a key sign!

[Seb Hinde @sebh2005]

Academic publishing scams are getting very good, having had a paper published yesterday this came through soon after. If it wasn't for the terrible grammar I would have clicked on the link. Be careful out there! I was so pleased I'd been nominated!

[Zanfina Ademi @ZANFINA]

Congratulations @dinaabushanab10 on this massive work on projecting the health and economic burden of CVD among people with type 2 diabetes @claremarquina @JedidiahMorton @PECjournal https://t.co/srCxZrwpZj

[Chris Carswell @PECjournal]

@PaulaLorgelly Kei te pēhea koe?

[David D. Kim (김대호) @ddkim62]

In preparation for my new class @HarrisPolicy, I asked ChatGPT:

“How to conduct cost-effectiveness analysis (CEA)?”

ChatGPT provides a very solid high-level summary, and I don’t think I can do a better job.

Thoughts? @PeterNeumann11 @Basucally @AnkurFactorial @WrightCensored